Φορτώνει......
Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials
BACKGROUND: We characterized clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib who were long-term responders (LTRs), defined as patients having progression-free survival (PFS) >18 months. PATIENTS AND METHODS: A retrospective analysis of data from 57...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Genitourin Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736765/ https://ncbi.nlm.nih.gov/pubmed/28711490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2017.06.005 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|